Business
AstraZeneca unveils antibody treatment, preventative shot for those who can’t get vaccinated – The Sydney Morning Herald
The company said its drug offered hope to those who can’t receive COVID-19 vaccines, such as cancer patients, organ transplant…
The full results will be submitted for publication in a peer-reviewed medical journal.
Pascal Soriot, CEO of AstraZeneca, said the data showed the drug offered protection for six months and could last for 12 months, but the company needed a further six…
Continue Reading
-
Noosa News24 hours agoWhy Brisbane needs to (re)embrace Los Angeles
-
General23 hours agoUK names Sarah Mullally as first female Archbishop of Canterbury to lead Church of England
-
General23 hours agoSussan Ley responds to Andrew Hastie’s Shadow Cabinet resignation
-
General21 hours agoa pivotal moment in Liberal power struggle